 |
|
Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, Irsan Hasan, Lyana Setiawan, Ming-Lung Yu, Namiki Izumi, Nguyen Nguyen Huyen, Pierce Kah-Hoe Chow, Rosmawati Mohamed, Stephen Lam Chan, Tawesak Tanwandee, Teng-Yu Lee, Thi Thanh Nguyen Hai, Tian Yang, Woo-Chang Lee, Henry Lik Yuen Chan
Clin Mol Hepatol. 2023;29(2):277-292. Published online 2023 Jan 30 DOI: https://doi.org/10.3350/cmh.2022.0212
|
|
Citations to this article as recorded by
 Surveillance for Hepatocellular Carcinoma in Cirrhosis: End of Monopoly for Serum Alpha Fetoprotein
Lung-Yi Mak, Man-Fung Yuen
Gastroenterology.2025; 168(2): 217. CrossRef Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies
Jinlin Hou, Thomas Berg, Arndt Vogel, Teerha Piratvisuth, Jörg Trojan, Enrico N. De Toni, Masatoshi Kudo, Katarina Malinowsky, Peter Findeisen, Johannes Kolja Hegel, Wenzel Schöning, Kairat Madin, Konstantin Kroeniger, Henry Lik-Yuen Chan, Ashish Sharma
JHEP Reports.2025; 7(2): 101263. CrossRef Rapid evaluation of hepatocellular carcinoma by detecting plasma exosomes with time-resolved fluorescence immunochromatographic test strips
Jiaming Li, Jianfen Su, Minghui Li, Yaofen Wu, Huiqiang Chen, Xihua Fu, Hongliang Yao, Jinping Chen, Yuntao Liu, Jie Zan
Microchimica Acta.2025;[Epub] CrossRef Prognostic Value of the ASAP Score for Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multicenter Analysis of 1,239 Patients
Tian Yang, Dong-Xu Yin, Yong-Kang Diao, Ming-Da Wang, Xian-Ming Wang, Yong-Yi Zeng, Zhong Chen, Han Liu, Fu-Jie Chen, Yu-Chen Li, Jia-Hao Xu, Han Wu, Lan-Qing Yao, Xin-Fei Xu, Chao Li, Li-Hui Gu, Alfred W. Chieh Kow, Timothy M. Pawlik, Feng Shen
Journal of Clinical and Experimental Hepatology.2025; 15(3): 102497. CrossRef Predicting hepatocellular carcinoma outcomes and immune therapy response with ATP-dependent chromatin remodeling-related genes, highlighting MORF4L1 as a promising target
Chao Xu, Litao Liang, Guoqing Liu, Yanzhi Feng, Bin Xu, Deming Zhu, Wenbo Jia, Jinyi Wang, Wenhu Zhao, Xiangyu Ling, Yongping Zhou, Wenzhou Ding, Lianbao Kong
Cancer Cell International.2025;[Epub] CrossRef Cluster analysis of hepatocellular carcinoma prognosis using preoperative alpha-fetoprotein and des-gamma-carboxy prothrombin levels: a multi-institutional study
Yoshitaka Saegusa, Yuki Imaoka, Masahiro Ohira, Tsuyoshi Kobayashi, Naruhiko Honmyo, Michinori Hamaoka, Takashi Onoe, Daisuke Takei, Koichi Oishi, Tomoyuki Abe, Toshihiro Nakayama, Miho Akabane, Kazunari Sasaki, Hideki Ohdan
Journal of Gastrointestinal Surgery.2025; 29(4): 101980. CrossRef 3D synergistic tumor-liver analysis further improves the efficacy prediction in hepatocellular carcinoma: a multi-center study
Yurong Jiang, Jiawei Zhang, Zhaochen Liu, Jinxiong Zhang, Xiangrong Yu, Danyan Lin, Dandan Dong, Mingyue Cai, Chongyang Duan, Shuyi Liu, Wenhui Wang, Yuan Chen, Qiyang Li, Weiguo Xu, Meiyan Huang, Sirui Fu
BMC Cancer.2025;[Epub] CrossRef Teaching design for chapter “primary liver cancer” in surgery course based on the clinical theory and clerkship synchronization model in the era of New Medicine
Feng Ye, Qiang Cai, Xiaoyong Gong, Jiajun Ren, Ruixin Sun, Chang Liu, Xiaoli Wang, Yuan Qiao
Global Medical Education.2025;[Epub] CrossRef Development and validation of a new prognostic tool for hepatocellular carcinoma undergoing resection: The Weighted Alpha-Fetoprotein Tumor Burden Score (WATS)
Tonghui Lu, Kailing Xie, Yan Chen, Mingxiu Ma, Yaming Guo, Tianqiang Jin, Chaoliu Dai, Feng Xu
European Journal of Surgical Oncology.2025; 51(6): 109677. CrossRef Divergent trends in cirrhosis and liver cancer highlight the ongoing efforts required for hepatitis elimination
Grace Lai-Hung Wong, Henry Lik-Yuen Chan
Hepatology.2025;[Epub] CrossRef CA19-9, CEA and PIVKA-Ⅱ as a novel panel of serum markers for diagnosis of pancreatic cancer
Meifang Wang, Hongying Bu, Weijia Luo, Xi Zeng, Guodong Chen, Yingchun He, Deliang Cao
Clinical Biochemistry.2025; 137: 110902. CrossRef Tumor burden score combined with AFP and PIVKA-II (TAP score) to predict the prognosis of hepatocellular carcinoma patients after radical liver resection
Zhan-Cheng Qiu, You-Wei Wu, Jun-Long Dai, Wei-Li Qi, Chu-Wen Chen, Yue-Qing Xu, Jun-Yi Shen, Chuan Li, Tian-Fu Wen
Langenbeck's Archives of Surgery.2025;[Epub] CrossRef The Diagnostic Performance of AFP, AFP-L3, DCP, CA199, and Their Combination for Primary Liver Cancer
Yue Liu, Wenrong Jiang, Xiangxiao Li, Hu Zhao, Shiwen Wang
Journal of Hepatocellular Carcinoma.2025; Volume 12: 513. CrossRef 5-Hydroxymethylcytosine modifications in circulating cell-free DNA: frontiers of cancer detection, monitoring, and prognostic evaluation
Danjun Song, Zhou Zhang, Jiaping Zheng, Wei Zhang, Jiabin Cai
Biomarker Research.2025;[Epub] CrossRef Des-γ-carboxy Prothrombin in hepatocellular carcinoma post-operative recurrence risk evaluation
Xinting Pan, Yang Zhou, Zhenli Li, Pengfei Guo, Jianyang Zeng, Xiuqing Dong, En Hu, Liman Qiu, Zhixiong Cai, Geng Chen, Xiaolong Liu
Communications Medicine.2025;[Epub] CrossRef Role of protein induced by vitamin-K absence-II in transplanted patients with HCC not producing alpha-fetoprotein
Quirino Lai, Takashi Ito, Samuele Iesari, Toru Ikegami, Daniele Nicolini, Zoe Larghi Laureiro, Massimo Rossi, Marco Vivarelli, Tomoharu Yoshizumi, Etsurou Hatano, Jan Lerut
Liver Transplantation.2024; 30(5): 472. CrossRef PIVKA‐II combined with tumor burden score to predict long‐term outcomes of AFP‐negative hepatocellular carcinoma patients after liver resection
Zhan‐cheng Qiu, You‐wei Wu, Wei‐li Qi, Chuan Li
Cancer Medicine.2024;[Epub] CrossRef Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma
Ming-Da Wang, Yong-Kang Diao, Lan-Qing Yao, Zhong-Qi Fan, Ke-Chun Wang, Han Wu, Li-Hui Gu, Jia-Hao Xu, Chao Li, Guo-Yue Lv, Tian Yang
iLIVER.2024; 3(1): 100083. CrossRef Management Consensus Guidelines for Hepatocellular Carcinoma: 2023 Update on Surveillance, Diagnosis, Systemic Treatment, and Posttreatment Monitoring by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
Wei Teng, Hung-Wei Wang, Shi-Ming Lin
Liver Cancer.2024; 13(5): 468. CrossRef Development of a Reliable GADSAH Model for Differentiating AFP-negative Hepatic Benign and Malignant Occupying Lesions
Xiaoling Long, Huan Zeng, Yun Zhang, Qiulong Lu, Zhao Cao, Hong Shu
Journal of Hepatocellular Carcinoma.2024; Volume 11: 607. CrossRef Celestial Insights: Unraveling the Role of miR-3682-3p in Hepatocellular Carcinoma
Pei-Dong Miao, Ying Li, Yu-Dong Jiang
Clinical and Translational Gastroenterology.2024; 15(4): e00690. CrossRef Research progress of protein induced by vitamin K absence or antagonist II in liver transplantation for hepatocellular carcinoma
Zheyu Zhou, Qiaoyu Liu, Jinsong Liu, Wenwen Li, Shuya Cao, Jiawei Xu, Jun Chen, Xiaoliang Xu, Chaobo Chen
Heliyon.2024; 10(9): e30622. CrossRef Optimizing care of HBV infection and HBV-related HCC
Shi Yan Lee, Benjamin Kai Yi Nah, Jazleen Leo, Jia Hong Koh, Daniel Q. Huang
Clinical Liver Disease.2024;[Epub] CrossRef Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
Jiwon Hong, Jung Woo Eun, Geum Ok Baek, Jae Youn Cheong, Seryoung Park, Soon Sun Kim, Hyo Jung Cho, Su Bin Lim
Clinical and Molecular Hepatology.2024; 30(3): 360. CrossRef Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients
Mingda Wang, Guojun Qian, Hongmei Xiao, Xingkai Liu, Liyang Sun, Zhong Chen, Kongying Lin, Lanqing Yao, Chao Li, Lihui Gu, Jiahao Xu, Xiaodong Sun, Wei Qiu, Timothy M Pawlik, Wan Yee Lau, Guoyue Lv, Feng Shen, Tian Yang
The Oncologist.2024; 29(12): e1723. CrossRef The ARH score, a practical guide to decision-making for retreatment with hepatic arterial infusion chemotherapy in hepatocellular carcinoma patients
Jie Mei, Chengyou Yu, Feng Shi, Renguo Guan, Shaohua Li, Chong Zhong, Rongping Guo, Wei Wei
International Immunopharmacology.2024; 138: 112551. CrossRef Monocyte distribution width as a promising biomarker for differential diagnosis of chronic hepatitis, cirrhosis, and hepatocellular carcinoma
Sheng Lin, Xinyao Yang, Xin Yang, Minjie Tang, Xiaobao Yao, Yuchen Ye, Qunfang Huang, Jinlan Huang, Jiejuan Li, Qiang Yi, Wennan Wu, Shiqi Li, Yaru Lei, Bin Yang, Can Liu, Qishui Ou, Zhen Xun
Frontiers in Immunology.2024;[Epub] CrossRef Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment
Rosmawati Mohamed, Wendy Wang, Tawesak Tanwandee, Irsan Hasan, Cam Phuong Pham, Young-Suk Lim, Sheng-Nan Lu, Murallitharan Munisamy, Thi Thanh Huong Tran, Evy Ratnawati, Wattana Sukeepaisarnjaroen, Mahir Karababa, Chee-Kiat Tan
Journal of Gastrointestinal Cancer.2024; 55(3): 1333. CrossRef Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma
Ji Yeon Lee, Pil Soo Sung
Gut and Liver.2024; 18(4): 558. CrossRef Prognosis of Patients with Hepatocellular Carcinoma Treated with TACE: A New Score Combining Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin
Shang-Yu Lu, Han-Yao Sun, Yan Zhou, Xi Luo, Sheng Liu, Wei-Zhong Zhou, Hai-Bin Shi, Wei Yang, Wei Tian
Journal of Hepatocellular Carcinoma.2024; Volume 11: 1979. CrossRef CEUS LI-RADS in Combination With the Serum Biomarker-Based ASAP Model Improves the Diagnostic Performance of HCC in High-Risk Patients
Rong Wen, Yuting Peng, Yiqiong Liang, Yuquan Wu, Haiyuan Li, Yanxia Chen, Yan Qin, Zhiyuan Wen, Huanyu Cui, Yun He, Hong Yang
Ultrasound in Medicine & Biology.2024; 50(11): 1739. CrossRef Disease modifiers and novel markers in hepatitis B virus-related hepatocellular carcinoma
Lung-Yi Mak
Journal of Liver Cancer.2024; 24(2): 145. CrossRef Construction and evaluation of a liver cancer risk prediction model based on machine learning
Ying-Ying Wang, Wan-Xia Yang, Qia-Jun Du, Zhen-Hua Liu, Ming-Hua Lu, Chong-Ge You
World Journal of Gastrointestinal Oncology.2024; 16(9): 3839. CrossRef Early identification of hepatocellular carcinoma patients at high-risk of recurrence using the ADV score: a multicenter retrospective study
Shuya Cao, Zheyu Zhou, Chaobo Chen, Wenwen Li, Jinsong Liu, Jiawei Xu, Chunlong Zhao, Yihang Yuan, Zhenggang Xu, Huaiyu Wu, Guwei Ji, Xiaoliang Xu, Ke Wang
World Journal of Surgical Oncology.2024;[Epub] CrossRef Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
Yau-Tuen Chan, Cheng Zhang, Junyu Wu, Pengde Lu, Lin Xu, Hongchao Yuan, Yibin Feng, Zhe-Sheng Chen, Ning Wang
Molecular Cancer.2024;[Epub] CrossRef Combined DeRitis ratio and alkaline phosphatase on the prediction of portal vein tumor thrombosis in patients with hepatocellular carcinoma
Tong-Guo Miao, Shi-Ya Zhang, Yun-Jing Zhang, Dong Ma, Yue-Min Nan
Scientific Reports.2024;[Epub] CrossRef Liquid Chromatography/Tandem Mass Spectrometry-Based Simultaneous Analysis of 32 Bile Acids in Plasma and Conventional Biomarker-Integrated Diagnostic Screening Model Development for Hepatocellular Carcinoma
Minami Yamauchi, Masamitsu Maekawa, Toshihiro Sato, Yu Sato, Masaki Kumondai, Mio Tsuruoka, Jun Inoue, Atsushi Masamune, Nariyasu Mano
Metabolites.2024; 14(9): 513. CrossRef Comparison of laparoscopic hepatectomy and radiofrequency ablation for small hepatocellular carcinoma patients: a SEER population-based propensity score matching study
Xi Wang, Xinqun Chai, Ruiya Tang, Yunjie Xu, Qinjunjie Chen
Updates in Surgery.2024; 76(8): 2755. CrossRef Multi-stage mechanisms of tumor metastasis and therapeutic strategies
Zaoqu Liu, Jingqi Chen, Yuqing Ren, Shutong Liu, Yuhao Ba, Anning Zuo, Peng Luo, Quan Cheng, Hui Xu, Xinwei Han
Signal Transduction and Targeted Therapy.2024;[Epub] CrossRef An Early Increase in IL-10 and TNF-α Levels Following Atezolizumab Plus Bevacizumab Treatment Predicts Survival in Advanced Hepatocellular Carcinoma Patients: A Prospective Cohort Study
Soon Kyu Lee, Soon Woo Nam, Ji Won Han, Jung Hyun Kwon
Cancers.2024; 16(20): 3543. CrossRef Prediction of microvascular invasion in hepatocellular carcinoma with conventional ultrasound, Sonazoid-enhanced ultrasound, and biochemical indicator: a multicenter study
Dan Lu, Li-Fan Wang, Hong Han, Lin-Lin Li, Wen-Tao Kong, Qian Zhou, Bo-Yang Zhou, Yi-Kang Sun, Hao-Hao Yin, Ming-Rui Zhu, Xin-Yuan Hu, Qing Lu, Han-Sheng Xia, Xi Wang, Chong-Ke Zhao, Jian-Hua Zhou, Hui-Xiong Xu
Insights into Imaging.2024;[Epub] CrossRef Cross-sectional study on the diagnostic significance of plasma exosomal miRNAs in HBV-related hepatocellular carcinoma
Xiaoyuan Hu, Fa Huang, Jiyou Yao, Jiaxian Lv, Jialuo Mai, Ning Li, Minqiang Lu
Journal of Translational Medicine.2024;[Epub] CrossRef Establishment of sex-specific reference intervals for PIVKA-II in Southwest China: A real-world data analysis
Bin Wei, Yalin Zheng, Lixin Li, Limei Luo, Ying Guo
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine.2024;[Epub] CrossRef Prognostic significance of early alpha fetoprotein and des-gamma carboxy prothrombin responses in unresectable hepatocellular carcinoma patients undergoing triple combination therapy
Teng Zhang, Wengang Li, Qian Chen, Weiping He, Jing Sun, Dong Li, Quan Wang, Xuezhang Duan
Frontiers in Immunology.2024;[Epub] CrossRef Comparative Validation of Prediction Models for HCC Outcomes in Living Donor Liver Transplantation: Superiority of Tumor Markers to Imaging Study
Hwa‐Hee Koh, Minyu Kang, Deok‐Gie Kim, Jae Hyon Park, Eun‐Ki Min, Jae Geun Lee, Myoung Soo Kim, Dong Jin Joo
Journal of Gastroenterology and Hepatology.2024;[Epub] CrossRef Evolution of Liver Resection for Hepatocellular Carcinoma: Change Point Analysis of Textbook Outcome over Twenty Years
Yeshong Park, Ho-Seong Han, Seung Yeon Lim, Hyelim Joo, Jinju Kim, MeeYoung Kang, Boram Lee, Hae Won Lee, Yoo-Seok Yoon, Jai Young Cho
Medicina.2024; 61(1): 12. CrossRef Efficacy and safety of the combination of envafolimab and lenvatinib in unresectable hepatocellular carcinoma: a single-arm, multicentre, exploratory phase II clinical study
Yi Jiang, Ke Su, Han Li, Chenjie Wang, Zhenying Wu, Jiali Chen, Zhiyao Zhang, Kun He, Yunwei Han
Investigational New Drugs.2024;[Epub] CrossRef What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
Min Kyung Park, Yoon Jun Kim
Clinical and Molecular Hepatology.2023; 29(2): 332. CrossRef Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in Taiwan
San-Chi Chen
Clinical and Molecular Hepatology.2023; 29(2): 352. CrossRef Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers
Shu An, Xiaoxia Zhan, Min Liu, Laisheng Li, Jian Wu
Diagnostics.2023; 13(8): 1442. CrossRef Efficacy and Safety of Transarterial Chemoembolization with a Three-Stage Mixed Chemoembolic Regimen for Large Unresectable Hepatocellular Carcinoma
Yanjie Yang, Nan Du, Jingqin Ma, Zhijie Peng, Bo Zhou, Jiaze Yu, Xin Zhou, Wen Zhang, Zhiping Yan
Journal of Hepatocellular Carcinoma.2023; Volume 10: 1897. CrossRef Attenuation of binuclear hepatocytes in the paracancerous liver tissue is associated with short‐term recurrence of hepatocellular carcinoma post‐radical surgery
Yifan Zhang, Nan Wang, Fengjie Hao, Yongjun Chen, Xiaochun Fei, Junqing Wang
The FASEB Journal.2023;[Epub] CrossRef Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients
Tianying Ren, Xu Hou, Xin Zhang, Dongliang Chen, Juan Li, Yingnan Zhu, Zhiheng Liu, Dawei Yang
Heliyon.2023; 9(11): e21906. CrossRef Protein induced by vitamin K absence or antagonist II: Experience to date and future directions
Libin Dong, Xun Qiu, Fengqiang Gao, Kai Wang, Xiao Xu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2023; 1878(6): 189016. CrossRef Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area
Joo Hyun Oh, Jonghyun Lee, Eileen L. Yoon, Soung Won Jeong, Soon Sun Kim, Young Eun Chon, Sang Bong Ahn, Dae Won Jun
Cancers.2023; 16(1): 150. CrossRef
|